Singapore markets close in 43 minutes
Straits Times Index
3,301.64 -1.55 (-0.05%) Nikkei
38,835.10 +599.03 (+1.57%) Hang Seng
18,467.17 -111.13 (-0.60%) FTSE 100
8,282.49 +69.00 (+0.84%) Bitcoin USD
63,785.32 -750.95 (-1.16%) CMC Crypto 200
1,369.13 +4.01 (+0.29%)
Corvus Pharmaceuticals, Inc. (CRVS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.9200 |
| Open | 2.0900 |
| Bid | 1.8700 x 100 |
| Ask | 1.9800 x 100 |
| Day's range | 1.8300 - 2.0900 |
| 52-week range | 1.0500 - 4.1900 |
| Volume | |
| Avg. volume | 214,261 |
| Market cap | 93.664M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Corvus Pharmaceuticals Inc (CRVS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Explore key financial outcomes, strategic updates, and expert insights from Corvus Pharmaceuticals' first quarter of 2024 earnings call.
- Zacks
Here's Why Corvus (CRVS) is Poised for a Turnaround After Losing -25% in 4 Weeks
The heavy selling pressure might have exhausted for Corvus (CRVS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- Zacks
Down -18.35% in 4 Weeks, Here's Why Corvus (CRVS) Looks Ripe for a Turnaround
Corvus (CRVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
© 2024 Yahoo. All rights reserved.